TURN (180 Degree Capital) Unearned Income : $0.00 Mil (As of Jun. 2024)

View and export this data going back to 1992. Start your Free Trial

What is 180 Degree Capital Unearned Income?

180 Degree Capital's Unearned Income for the quarter that ended in Jun. 2024 was $0.00 Mil.

180 Degree Capital Unearned Income Historical Data

The historical data trend for 180 Degree Capital's Unearned Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

180 Degree Capital Unearned Income Chart

180 Degree Capital Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Unearned Income

Get a 7-Day Free Trial

180 Degree Capital Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Unearned Income	Get a 7-Day Free Trial															-	-	-	-	-

180 Degree Capital Unearned Income Calculation

Unearned Income is the income received but not yet earned, it represents the unearned amount that is netted against the total loan.

180 Degree Capital Unearned Income Related Terms

Thank you for viewing the detailed overview of 180 Degree Capital's Unearned Income provided by GuruFocus.com. Please click on the following links to see related term pages.

180 Degree Capital Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » 180 Degree Capital Corp (NAS:TURN) » Definitions » Unearned Income

Comparable Companies

Traded in Other Exchanges

N/A

Address

7 N. Willow Street, Suite 4B, Montclair, NJ, USA, 07042

Website

https://www.180degreecapital.com

180 Degree Capital Corp is active in the financial services domain. It is a non-diversified closed-end management investment company whose objective is to achieve long-term capital appreciation by making venture capital investments. It focuses its investments on companies commercializing and integrating products enabled by disruptive technologies mainly in the life sciences, precision medicine, and health industries.

Executives

Kevin Rendino	director	800 SCUDDERS MILL RD, PLAINSBORO NJ 08536
Daniel B Wolfe	officer: Vice President	HARRIS & HARRIS GROUP, 111 WEST 57TH STREET, SUITE 1100, NEW YORK NY 10019
Bigelow Robert E Iii	officer: VP, Head of Fund Development	7 NORTH WILLOW STREET SUITE 4B, MONTCLAIR NJ 07042
Alicia M Gift	officer: Treasurer, Secretary	1450 BROADWAY, 24TH FLOOR, NEW YORK NY 10018
Richard P Shanley	director	111 WEST 57TH STREET, NEW YORK NY 10019
Tonia L Pankopf	director	8 SOUND SHORE DR STE 215, GREENWICH CT 06830
Parker Anders Weil	director	262 MCKINLEY PLACE, RIDGEWOOD NJ 07450
Stacy Brandom	director	1450 BROADWAY, NEW YORK NY 10018
Robert Stephen Burns	officer: Senior Vice President	1450 BROADWAY, NEW YORK NY 10018
Bruce W Shewmaker	director	12 BRIAR WOOD DRIVE, SHORT HILLS NJ 07078
Lucio Lanza	director	141 CASPIAN COURT, SUNNYVALE CA 94089
Misti Ushio	officer: Vice President	111 WEST 57TH STREET, NEW YORK NY 10019
Charles E Ramsey	director	111 WEST 57TH STREET, SUITE 1100, NEW YORK NY 10019
Ayres W Dillaway Jr	director	111 WEST 57TH STREET, SUITE 1100, NEW YORK NY 10019
Michael A Janse	officer: Executive Vice President	111 WEST 57TH STREET SUITE 1100, NEW YORK NY 10019